Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-142 (vornorexant) repeated-dose PK/PD study in healthy Japanese participants
NCT04087707Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Sep 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vornorexant in Insomnia, sponsored by Taisho Pharmaceutical. Started Sep 2019; status: completed.
02
Drugs
vornorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04087707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04087707.